Scynexis (SCYX) Cash & Equivalents (2013 - 2026)
Scynexis (SCYX) reported Cash & Equivalents of $36.7 million for Q1 2026, up 428.25% on a YoY basis from $6.9 million in Q1 2025, and up 72.5% quarter-over-quarter from $21.3 million in Q4 2025.
Scynexis (SCYX) Cash & Equivalents (2013 - 2026) Analysis & Trends
Scynexis has reported Cash & Equivalents for 14 years, with the latest figure at $36.7 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Equivalents rose 428.25% year-over-year to $36.7 million; the trailing twelve-month figure through Mar 2026 stood at $36.7 million (up 428.25% YoY), and the FY2025 full-year result was $21.3 million, up 32.45% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $36.7 million, up from $21.3 million in the prior quarter.
- The five-year high for Cash & Equivalents was $118.7 million in Q2 2022, with the low at $6.9 million in Q1 2025.
- Historically, Cash & Equivalents has averaged $58.3 million across 5 years, with a median of $46.5 million in 2025.
- Annual changes were most pronounced in 2025 — Cash & Equivalents tumbled 92.63% — and 2026, when it jumped 428.25%.
- Scynexis' Cash & Equivalents stood at $45.8 million in 2022, then decreased by 25.68% to $34.0 million in 2023, then tumbled by 52.86% to $16.1 million in 2024, then soared by 32.45% to $21.3 million in 2025, then surged by 72.5% to $36.7 million in 2026.
- The last three Cash & Equivalents figures came in at $36.7 million (Q1 2026), $21.3 million (Q4 2025), and $14.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.28 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 40.42 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 266.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 351.55 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 222.27 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | 36.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.67 Mn |
| Dec 31, 2025 | 21.26 Mn |
| Sep 30, 2025 | 14.80 Mn |
| Jun 30, 2025 | 46.50 Mn |
| Mar 31, 2025 | 6.94 Mn |
| Dec 31, 2024 | 16.05 Mn |
| Sep 30, 2024 | 28.73 Mn |
| Jun 30, 2024 | 83.70 Mn |
| Mar 31, 2024 | 94.20 Mn |
| Dec 31, 2023 | 34.05 Mn |
| Sep 30, 2023 | 105.20 Mn |
| Jun 30, 2023 | 91.90 Mn |
| Mar 31, 2023 | 54.80 Mn |
| Dec 31, 2022 | 45.81 Mn |
| Sep 30, 2022 | 96.10 Mn |
| Jun 30, 2022 | 118.69 Mn |
| Mar 31, 2022 | 95.21 Mn |
| Dec 31, 2021 | 104.48 Mn |
| Sep 30, 2021 | 100.11 Mn |
| Jun 30, 2021 | 112.40 Mn |